|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
MyMD Pharmaceuticals, Inc (MYMD) |
|
|
$2.47 0.00 (0.00%) as of 4:30 Fri 4/16
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
18,630,000 |
| Market
Cap: |
46.02(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.47 - $2.47 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile MyMD Pharmaceuticals is a clinical stage pharmaceutical company. Co. is focused on developing and commercializing two therapeutic platforms based on therapeutic targets, MYMD-1 and Supera-CBD. MYMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including (but not limited to) multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease and is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic analog of CBD being developed to treat various conditions, including, but not limited to, epilepsy, pain and anxiety/depression.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
175,000 |
185,000 |
| Total Buy Value |
$0 |
$0 |
$194,580 |
$209,880 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
2 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rivard Paul |
Chief Legal Officer |
• – – |
2023-08-24 |
4 |
B |
$1.11 |
$166,500 |
D/D |
150,000 |
400,000 |
2.74 |
- |
|
| Rivard Paul |
Chief Legal Officer |
• – – |
2023-08-17 |
4 |
B |
$1.12 |
$28,080 |
D/D |
25,000 |
250,000 |
2.74 |
- |
|
| Rivard Paul |
EVP of Operations, GC |
• – – |
2022-12-08 |
4 |
B |
$1.53 |
$15,300 |
D/D |
10,000 |
225,000 |
2.74 |
- |
|
| Rivard Paul |
EVP of Operations, GC |
• – – |
2021-11-23 |
4 |
B |
$6.03 |
$90,450 |
D/D |
15,000 |
215,000 |
2.74 |
-100% |
|
| Williams Caroline C |
10% Owner |
– – • |
2021-04-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,744,451 |
|
- |
|
| Williams Caroline C |
10% Owner |
– – • |
2021-04-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,272,972 |
|
- |
|
| Schreiber Christopher C |
Director |
– • – |
2021-04-16 |
4 |
D |
$4.94 |
$227,798 |
D/D |
(46,113) |
88,238 |
|
- |
|
| Schreiber Christopher C |
Director |
– • – |
2021-04-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
131,750 |
134,351 |
|
- |
|
| Chapman Christopher C Jr |
President, Chief Med. Officer |
• • – |
2021-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
96,475 |
96,475 |
|
- |
|
| Schroeder Robert C |
Director |
– • – |
2021-04-16 |
4 |
D |
$4.94 |
$72,588 |
D/D |
(14,694) |
29,236 |
|
- |
|
| Schroeder Robert C |
Director |
– • – |
2021-04-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
43,930 |
43,930 |
|
- |
|
| Silverman Joshua |
Director |
– • – |
2021-04-16 |
4 |
D |
$4.94 |
$189,326 |
D/D |
(38,325) |
71,175 |
|
- |
|
| Silverman Joshua |
Director |
– • – |
2021-04-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
109,500 |
112,101 |
|
- |
|
| White Billy Joe |
Director |
– • – |
2021-04-16 |
4 |
D |
$4.94 |
$189,326 |
D/D |
(38,325) |
71,175 |
|
- |
|
| White Billy Joe |
Director |
– • – |
2021-04-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
109,500 |
112,101 |
|
- |
|
| Gerber Sander |
10% Owner |
– – • |
2020-02-28 |
4 |
S |
$2.81 |
$1,793 |
I/I |
(638) |
240,305 |
|
-26% |
|
| Gerber Sander |
10% Owner |
– – • |
2020-02-27 |
4 |
S |
$2.72 |
$41,616 |
I/I |
(15,300) |
240,943 |
|
-24% |
|
| Gerber Sander |
10% Owner |
– – • |
2020-02-25 |
4 |
S |
$2.92 |
$37,960 |
I/I |
(13,000) |
256,243 |
|
-9% |
|
| Silverman Joshua |
Director |
– • – |
2020-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,201 |
5,201 |
|
- |
|
| Schreiber Christopher C |
Executive Chairman |
• • – |
2020-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,201 |
5,201 |
|
- |
|
| White Billy Joe |
Director |
– • – |
2020-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,201 |
5,201 |
|
- |
|
| Gerber Sander |
10% Owner |
– – • |
2019-12-20 |
4 |
B |
$3.02 |
$24,160 |
I/I |
8,000 |
269,243 |
1.5 |
- |
|
| Gerber Sander |
10% Owner |
– – • |
2019-12-19 |
4 |
B |
$3.08 |
$8,316 |
I/I |
2,700 |
261,243 |
1.5 |
- |
|
| Gerber Sander |
10% Owner |
– – • |
2019-12-18 |
4 |
B |
$3.07 |
$23,025 |
I/I |
7,500 |
258,043 |
1.5 |
- |
|
| Gerber Sander |
10% Owner |
– – • |
2019-12-17 |
4 |
B |
$3.03 |
$9,090 |
I/I |
3,000 |
251,043 |
1.5 |
- |
|
61 Records found
|
|
Page 1 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
